
Will Palantir Stock Split?
Shares of Palantir Technologies (NASDAQ:PLTR) have skyrocketed over the last…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Income Statement | ||||||
Revenue | $156.6B | $171.3B | $176.8B | $42.6B | $45.4B | |
Gross Profit | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
Diluted EPS | $24.60 | $25.17 | $25.61 | $3.63 | $1.81 |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $40.1B | $44.6B | $49.4B | $54B | $52.6B | |
Total Assets | $86.6B | $97.5B | $102.8B | $108.9B | $116.9B | |
Current Liabilities | $18.8B | $21.5B | $24.1B | $26.3B | $26.2B | |
Total Liabilities | $53.4B | $61.3B | $66.4B | $69.5B | $75.5B | |
Total Equity | $33.2B | $36.1B | $36.3B | $39.4B | $41.4B | |
Total Debt | $20B | $23B | $24.1B | $25.1B | $31.2B |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $8.4B | $8.1B | $5.8B | -$3B | $706M | |
Cash From Investing | -$4.6B | -$5.6B | -$5.2B | -$1B | -$1.6B | |
Cash From Financing | -$1.3B | -$3.3B | $1.2B | -$394M | $1.4B | |
Free Cash Flow | $7.2B | $6.8B | $4.6B | -$3.3B | $384M |
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
In the current month, ELV has received 12 Buy ratings 5 Hold ratings, and 0 Sell ratings. The ELV average analyst price target in the past 3 months is $494.29.
According to analysts, the consensus estimate is that Elevance Health share price will rise to $494.29 per share over the next 12 months.
Analysts are divided on their view about Elevance Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Elevance Health is a Sell and believe this share price will drop from its current level to $405.00.
The price target for Elevance Health over the next 1-year time period is forecast to be $494.29 according to 17 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Elevance Health is a Buy. 12 of 17 analysts rate the stock a Buy at this time.
You can purchase shares of Elevance Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Elevance Health shares.
Elevance Health was last trading at $402.31 per share. This represents the most recent stock quote for Elevance Health. Yesterday, Elevance Health closed at $385.10 per share.
In order to purchase Elevance Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Shares of Palantir Technologies (NASDAQ:PLTR) have skyrocketed over the last…
With a personal net worth of approximately $6.5 billion and…
The degree to which the healthcare paradigm has changed is…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.3T
P/E Ratio: 113x
Market Cap: $3T
P/E Ratio: 35x
Globant SA [GLOB] is up 2.83% over the past day.
Hims & Hers Health [HIMS] is down 19.28% over the past day.
Vicor [VICR] is down 5.16% over the past day.